Healthcare Practitioners Knowledge on Diabetes Technology

September 10, 2026 updated by: Prof. Triantafyllos Didangelos, Aristotle University Of Thessaloniki

Healthcare Professionals' Knowledge of Continuous Glucose Monitoring and Insulin Pump Therapy

Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Data will be collected using a standardized questionnaire. This questionnaire is based on a review of the relevant literature on diabetes management and related technologies. The final instrument consists of 37 closed-ended items. It was organized into four main sections, covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. Demographics will be also collected along with diabetes knowledge questions and 2 sections (1 for insulin pumps and 1 for continuous glucose monitoring).

Study Type

Observational

Enrollment (Estimated)

112

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Triantafyllos Didangelos, Professor of Internal Medicine
  • Phone Number: +302310994776
  • Email: didang@auth.gr

Study Contact Backup

Study Locations

  • Greece
      • Thessaloniki, Greece, 54636
        • Recruiting
        • University General of Thessaloniki AHEPA
        • Contact:
          • Triantafyllos Didangelos, Professor of Internal Medicine
          • Phone Number: +302310994776
          • Email: didang@auth.gr
        • Contact:
        • Principal Investigator:
          • Triantafyllos Didangelos, Professor of Internal Medicine
        • Principal Investigator:
          • Zisis Kontoninas, MD,PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthcare professionals practicing at the University General Hospital of Thessaloniki "AHEPA"

Description

Inclusion Criteria:

  • All qualified and registered HCP practicing at the University General Hospital of Thessaloniki "AHEPA" , who were involved in direct patient care.
  • Actively working during the data collection period.

Exclusion Criteria:

  • Administrative staff and personnel not directly involved in patient care.
  • HCP who declined to participate.
  • Participants who did not complete the questionnaire in full.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Observation group
Healthcare professionals working in a tertiary university hospital
Other: Questionnaire assessing knowledge on diabetes technology
A standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge of Diabetes Mellitus aspects
Time Frame: Through study completion, an average of 1 year and 3 months
Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.
Through study completion, an average of 1 year and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knowledge on insulin use
Time Frame: Through study completion, an average of 1 year and 3 months
The instrument was a questionnaire of 37 closed ended items organized in 4 sections covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. The questions for insulin use covered the knowledge of healthcare professionals on insulin regimens, dose calculation and administration, principles and benefits of insulin pump therapy, potential complications and appropriate actions in case of device malfunction.
Through study completion, an average of 1 year and 3 months
Knowledge of healthcare professionals on continuous glucose monitoring systems
Time Frame: Through study completion, an average of 1 year and 3 months
Questions on system function, accuracy, indications for use, contribution to glycemic control, sensor placement and common issues during use.
Through study completion, an average of 1 year and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aristotle University Of Thessaloniki

Investigators

  • Principal Investigator: Triantafyllos Didangelos, Aristotle University Of Thessaloniki
  • Study Director: Zisis Kontoninas, MD, PhD, Aristotle University Of Thessaloniki

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

September 4, 2026

First Submitted That Met QC Criteria

September 10, 2026

First Posted (Actual)

September 16, 2026

Study Record Updates

Last Update Posted (Actual)

September 16, 2026

Last Update Submitted That Met QC Criteria

September 10, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 219/2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because of the General Data Protection Regulation and the regulations of the Ethics committee of the hospital

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe